loading

Achieve Life Sciences Inc Stock (ACHV) Forecast

The Achieve Life Sciences Inc (ACHV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.1092, representing a -6.01% decrease from the current price of $6.50. The highest analyst price target is $7.2014, and the lowest is $5.017.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACHV Price Target
Average 4.8822 (-24.89% Downside)
loading

Is Achieve Life Sciences Inc (ACHV) A Buy Now?

Oscillators
Name Value Action
RSI(14) 36.57 Neutral
STOCH(9,6) 22.27 Neutral
STOCHRSI(14) 24.38 Neutral
MACD(12,26) -0.2862 Sell
ADX(14) 20.64 Neutral
William %R -77.78 Neutral
CCI(14) -61.85 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
6.7945
Sell
6.7494
Sell
MA20
7.1128
Sell
7.0079
Sell
MA50
7.5639
Sell
7.1431
Sell
MA100
6.785
Sell
6.7239
Sell
MA200
5.602
Buy
5.886
Buy
Buy: 2 Sell: 8 Neutral: 0
Summary: Sell
According to our latest analysis, ACHV could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ACHV, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 36.57 indicates that ACHV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 22.27 indicates that ACHV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.38 indicates that ACHV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 20.64 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -61.85 indicates that ACHV is still oversold but not to an extreme extent.

Long-term ACHV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Achieve Life Sciences Inc financial reports and earnings history, Achieve Life Sciences Inc (ACHV) stock could reach $3.1157 by 2030, $1.0124 by 2040 and $2.0715 by 2050. See the projected annual prices until 2050 of the Achieve Life Sciences Inc stock below:

  • Achieve Life Sciences Inc (ACHV) is expected to reach an average price of $1.1616 in 2035, with a high prediction of $2.066 and a low estimate of $0.7503. This indicates an $-82.13% rise from the last recorded price of $6.50.
  • Achieve Life Sciences Inc (ACHV) stock is projected to chart a bullish course in 2040, with an average price target of $0.2893, representing an $-95.55% surge from its current level. The forecast ranges from a conservative $0.0593 to a sky-high $1.0124.
  • Our analysts predict Achieve Life Sciences Inc (ACHV) to jump -29.87% by 2045, soaring from $4.3597 to an average price of $4.5584, potentially reaching $4.3584. While $4.3597 is the low estimate, the potential upside is significant.
  • Achieve Life Sciences Inc (ACHV) stock is expected to climb by 2050, reaching an average of $2.0715, a $-68.13% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.0715 and $2.4685, respectively, highlighting the market's uncertainty.

Achieve Life Sciences Inc Stock (ACHV) Year by Year Forecast

Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2026

The predicted value for Achieve Life Sciences Inc (ACHV) in 2026 is set at an average of $5.63. Estimates vary from a peak of $8.64 to a trough of $2.62, indicating an -13.38% surge from the present price of $6.50.
Month Average Low High Change from today's price
November, 2026 $5.347 $5.017 $7.2014 -17.74%
December, 2026 $6.0226 $4.6984 $6.2426 -7.34%

Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Achieve Life Sciences Inc (ACHV) is $3.5055, with a high forecast of $6.7654 and a low forecast of $0.2456. This indicates an -46.07% decrease from the last price of $6.50.
Month Average Low High Change from today's price
January, 2027 $5.9882 $5.654 $6.7654 -7.87%
February, 2027 $5.9538 $4.7796 $6.0838 -8.40%
March, 2027 $4.7209 $4.4109 $6.1353 -27.37%
April, 2027 $5.7265 $4.2223 $5.8165 -11.90%
May, 2027 $5.7235 $3.8026 $6.3029 -11.95%
June, 2027 $5.0891 $4.3849 $5.7049 -21.71%
July, 2027 $3.4547 $3.3447 $5.1744 -46.85%
August, 2027 $3.8017 $3.0089 $4.0936 -41.51%
September, 2027 $3.0073 $2.9859 $4.2716 -53.73%
October, 2027 $2.8129 $2.5629 $3.1187 -56.72%
November, 2027 $0.93 $0.90 $3.045 -85.69%
December, 2027 $0.2456 $0.2456 $1.1214 -96.22%

Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2028

In 2028, Achieve Life Sciences Inc (ACHV) is projected to reach an average price of $4.3973, with a high projection of $8.5677 and a low estimate of $0.227. This indicates an -32.35% fall from the last price of $6.50.
Month Average Low High Change from today's price
January, 2028 $0.9826 $0.227 $1.3398 -84.88%
February, 2028 $0.6882 $0.5968 $1.034 -89.41%
March, 2028 $3.1838 $0.6796 $3.4438 -51.02%
April, 2028 $3.7594 $2.8094 $4.1694 -42.16%
May, 2028 $2.6064 $2.4364 $3.7608 -59.90%
June, 2028 $5.512 $2.5378 $5.762 -15.20%
July, 2028 $5.4891 $4.1834 $8.5677 -15.55%
August, 2028 $4.2647 $3.8705 $6.6405 -34.39%
September, 2028 $3.3503 $3.1103 $4.6761 -48.46%
October, 2028 $3.6973 $3.2873 $4.1745 -43.12%
November, 2028 $3.2529 $2.7429 $3.8087 -49.96%
December, 2028 $2.6585 $2.5085 $3.8157 -59.10%

Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2029

The 2029 price forecast for Achieve Life Sciences Inc Stock (ACHV) is $2.8211 on average, with a high prediction of $4.2939 and a low estimate of $1.3482. This represents an -56.60% decrease from the previous price of $6.50.
Month Average Low High Change from today's price
January, 2029 $2.2255 $1.8058 $2.7899 -65.76%
February, 2029 $3.6111 $2.1312 $3.6111 -44.44%
March, 2029 $3.8268 $3.3825 $4.2939 -41.13%
April, 2029 $2.6138 $1.3482 $3.8382 -59.79%
May, 2029 $3.1794 $2.4252 $3.738 -51.09%
June, 2029 $2.385 $2.1536 $3.1322 -63.31%
July, 2029 $2.887 $2.2665 $3.156 -55.58%
August, 2029 $2.9576 $2.3634 $3.0427 -54.50%
September, 2029 $3.3532 $2.7104 $3.7119 -48.41%
October, 2029 $3.3302 $2.9902 $3.946 -48.77%
November, 2029 $2.9959 $2.803 $3.3859 -53.91%
December, 2029 $2.8729 $2.6229 $3.6373 -55.80%

Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2030

Achieve Life Sciences Inc Stock (ACHV) is expected to reach an average price of $1.9843 in 2030, with a high forecast of $3.7025 and a low forecast of $0.2662. This signifies an -69.47% decrease from the last price of $6.50.
Month Average Low High Change from today's price
January, 2030 $2.9085 $2.4771 $3.1157 -55.25%
February, 2030 $3.4041 $2.6677 $3.6541 -47.63%
March, 2030 $3.0697 $2.9897 $3.6655 -52.77%
April, 2030 $2.8067 $2.5153 $3.7025 -56.82%
May, 2030 $2.0423 $2.0009 $3.0545 -68.58%
June, 2030 $1.4979 $1.4279 $2.2665 -76.95%
July, 2030 $1.5849 $1.2493 $2.2035 -75.62%
August, 2030 $1.2306 $0.9292 $1.6478 -81.07%
September, 2030 $0.4176 $0.2662 $1.412 -93.58%
October, 2030 $0.7832 $0.389 $1.1231 -87.95%
November, 2030 $2.2688 $0.8446 $2.7388 -65.10%
December, 2030 $0.6258 $0.443 $2.3452 -90.37%
$3.73
price down icon 2.10%
$6.19
price down icon 3.43%
$1.49
price down icon 4.49%
$14.50
price up icon 2.26%
WVE WVE
$3.35
price down icon 0.59%
ANL ANL
$10.58
price down icon 6.04%
Cap:     |  Volume (24h):